Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited)

v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (62,734) $ (33,442)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 23 20
Common stock issued to acquire in-process research and development 3,000 1,360
Stock-based compensation 5,603 2,005
Changes in operating assets and liabilities:    
Prepaid expenses and other (1,217) (3,662)
Accounts payable 3,370 (1,301)
Operating lease liabilities and ROU asset, net (10) 8
Accrued expenses and other current liabilities (1,147) 360
Net cash used in operating activities (53,112) (34,652)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchase of property and equipment (9,685) (4,030)
Net cash used in investing activities (9,685) (4,030)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from exercise of warrants 2 9,896
Proceeds from ESPP 96 2
Proceeds, net of $0 and $711 expenses, from sale of preferred stock 4,602
Proceeds, net of $9,329 and $3,740 expenses, from sale of common stock and warrants 168,622 68,746
Net cash provided by financing activities 168,720 83,246
Effect of currency rate change on cash (21) (16)
Net increase in cash, cash equivalents and restricted cash 105,902 44,548
Cash, cash equivalents and restricted cash beginning of the period 77,308 11,349
Cash, cash equivalents and restricted cash end of period 183,210 55,897
Supplemental disclosures of cash flow information:    
Warrants deemed dividend 451
Series B Convertible preferred stock and deemed dividend $ 1,260